LURIE INVESTMENT FUND
Lurie Investment Fund is the venture capital arm of the Ann and Robert H. Lurie Foundation specializing in venture capital and private equity investments. The firm seeks to invest in biomedical community, mainly in medical devices, therapeutics, diagnostics and services, nanotechnology, and MEMS technology.
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Andrรฉ de Bruin Board Member @ Lurie Investment Fund Board_member
Current Employees Featured
Ann Lurie
Ann Lurie Trustee @ Lurie Investment Fund Trustee
William White
William White Executive Vice President @ Lurie Investment Fund Executive Vice President
Kristopher Wood
Kristopher Wood Chief Investment Officer @ Lurie Investment Fund Chief Investment Officer
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2012-01-06 | NanoInk | Lurie Investment Fund investment in Series E - NanoInk | 88 M USD |
2012-01-04 | CytoPherx | Lurie Investment Fund investment in Series C - CytoPherx | 34 M USD |
2010-06-17 | CytoPherx | Lurie Investment Fund investment in Series B - CytoPherx | 11.7 M USD |
2010-01-08 | Discera | Lurie Investment Fund investment in Series D - Discera | 11 M USD |
2009-07-07 | Viamet Pharmaceuticals | Lurie Investment Fund investment in Series B - Viamet Pharmaceuticals | 25 M USD |
2008-08-05 | HandyLab | Lurie Investment Fund investment in Series D - HandyLab | 19.2 M USD |
2008-06-24 | Aperion Biologics | Lurie Investment Fund investment in Series C - Aperion Biologics | 12.43 M USD |
2007-12-04 | Cernium | Lurie Investment Fund investment in Venture Round - Cernium | 10 M USD |
2007-10-22 | CytoPherx | Lurie Investment Fund investment in Series A - CytoPherx | 2.5 M USD |
2006-09-07 | RenaMed Biologics | Lurie Investment Fund investment in Venture Round - RenaMed Biologics | 40 M USD |